3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Melanoma
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Uveal Melanoma
2
Osteosarcoma
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Interventions
Melphalan
5
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
pomalidomide
1
ixazomib
1
elotuzumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
carfilzomib
1
auricularum
1
Stem Cell Transplantation
1
Sirolimus
1
Panobinostat
1
Lenalidomide
1
High-Throughput Screening Assays
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Calcium Dobesilate
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Plasma Cell
×
Colony-Stimulating Factors
×
Clear all
No trials found.